3-ETHOXYCARBONYL-9A-PHENYL-1,3,3A,4,5,9B-HEXAHYDROISOXAZOLO-[4,3-C]-QUINOLIN-2-ONE
Compound with spectra: 1 NMR
![3-ETHOXYCARBONYL-9A-PHENYL-1,3,3A,4,5,9B-HEXAHYDROISOXAZOLO-[4,3-C]-QUINOLIN-2-ONE](/api/compound/8fLErJoiGcm.png?ph=true&h=300&w=458 "3-ETHOXYCARBONYL-9A-PHENYL-1,3,3A,4,5,9B-HEXAHYDROISOXAZOLO-[4,3-C]-QUINOLIN-2-ONE")
| SpectraBase Compound ID | 8fLErJoiGcm |
|---|---|
| InChI | InChI=1S/C19H18N2O4/c1-2-24-18(23)16-15-17(22)20-14-11-7-6-10-13(14)19(15,21-25-16)12-8-4-3-5-9-12/h3-11,15-16,21H,2H2,1H3,(H,20,22)/t15-,16-,19?/m1/s1 |
| InChIKey | RAYFTHJTDOXGCA-QNRNLVPOSA-N |
| Mol Weight | 338.36 g/mol |
| Molecular Formula | C19H18N2O4 |
| Exact Mass | 338.126657 g/mol |
| Enantiomer InChIKey | RAYFTHJTDOXGCA-NRAVZPKASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Indeno[1,2-b]oxireno[c]pyridazin-9-ol, 9-ethyl-1a,2,3,9-tetrahydro-, (1a.alpha.,9.beta.,9aS*)-(.+-.)-
4-(2-Hydroxy-5-nitrophenyl)-3-methyl-4,7,8,9-tetrahydroisoxazolo[5,4-b]quinolin-5(6H)-one
Di-tert-butyl 1-(2-oxo-3-o-tolylindolin-3-yl)hydrazine-1,2-dicarboxylate
3-Hydroxy-3-(6-methoxy-7-methyl-1-oxo-1,2,3,4-tetrahydro-2-naphthalenyl)-1-methyl-1,3-dihydro-2H-indol-2-one
4a.beta.,5.beta.-(isopropylidenedioxy)-7-methoxy-1,2,3,4,4a,5,12,12a.alpha.-octahydro-2,6,11-naphthacenetrione
trans-5-Azido-5,6-dihydro-7,12-dimethylbenz[a]anthracen-6-ol
6-METHOXY-KAEMPFEROL-3-O-BETA-D-6''-(PARA-COUMAROYL)-GLUCOPYRANOSIDE
4-Carbomethoxy-6-methoxy-tetracyclo(5.4.0.0/2,4/.0/3,6/)undeca-1(7),8,10-triene
(1R,1'R)-1,8-Diethyl-1-(1',2'-dipropionyloxy)ethyl-1,3,4,9-tetrahydropyran[3,4-b]indole
(1R*,4S*,7R*)-1,2,3,4,7-Pentachloro-7-methoxy-5-phenylbicyclo[2.2.1]hept-2-ene
| Title | Journal or Book | Year |
|---|---|---|
| Steric control of reactivity: formation of oximes, benzodiazepinone N-oxides and isoxazoloquinolinones | Journal of the Chemical Society, Perkin Transactions 2 | 1998 |